Utility of cerebrospinal fluid cytology in newly diagnosed childhood ependymoma

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 6, 2010, Pages 515-518

  Moreno, Lucas ^a   Pollack, Ian F ^b   Duffner, Patricia K ^c   Geyer, J Russell ^d   Grill, Jacques ^f   Massimino, Maura ^g   Finlay, Jonathan L ^e   Zacharoulis, Stergios ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

CSF cytology; Metastatic ependymoma; Prognosis

Indexed keywords

ARTICLE; CANCER RELAPSE; CEREBROSPINAL FLUID CYTOLOGY; CHILD; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; EPENDYMOMA; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; BRAIN TUMOR; CANCER STAGING; CEREBROSPINAL FLUID; KAPLAN MEIER METHOD; MORTALITY; PROPORTIONAL HAZARDS MODEL;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EPENDYMOMA; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS;

EID: 77955896907     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181d7adf5     Document Type: Article

References (20)

1. Glass JP, Melamed M, Chernik NL, et al. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology. 1979;29:1369-1375.
2. Glantz MJ, Cole BF, Glantz LK, et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer. 1998;82:733-739.
3. Gajjar A, Fouladi M, Walter AW, et al. Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors. J Clin Oncol. 1999;17:1825-1828.
4. Fouladi M, Gajjar A, Boyett JM, et al. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblas-toma or primitive neuroectodermal tumor. J Clin Oncol. 1999; 17:3234-3237.
5. Zacharoulis S, Ji L, Pollack IF, et al. Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors. Pediatr Blood Cancer. 2008;50:231-235.
6. Reni M, Gatta G, Mazza E, Vecht C. Ependymoma. Crit Rev Oncol Hematol. 2007;63:81-89.
7. Almeida SM, Nanakanishi E, Conto AJ, et al. Cerebrospinal fluid cytological and biochemical characteristics in the presence of CNS neoplasia. Arq Neuropsiquiatr. 2007;65:802-809.
8. Poltinnikov IM, Merchant TE. CSF cytology has limited value in the evaluation of patients with ependymoma who have MRI evidence of metastasis. Pediatr Blood Cancer. 2006;47:169-173.
9. Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery. 1995;37:655-666.
10. Duffner PK, Krischer JP, Sanford RA, et al. Prognostic factors in infants and very young children with intracranial ependy-momas. Pediatr Neurosurg. 1998;28:215-222.
11. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol. 2005;23:7621-7631.
12. Grill J, Le Deley MC, Gambarelli D, et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol. 2001;19:1288-1296.
13. Schild SE, Nisi K, Scheithauer BW, et al. The results of radiotherapy for ependymomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 1998;42:953-958.
14. Massimino M, Gandola L, Giangaspero F, et al. Hyper-fractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int J Radiat Oncol Biol Phys. 2004;58:1336-1345.
15. Zacharoulis S, Levy A, Chi SN, et al. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer. 2007;49:34-40.
16. Yuh EL, Barkovich AJ, Gupta N. Imaging of ependymomas: MRI and CT. Childs Nerv Syst. 2009;25:1203-1213.
17. Qian X, Goumnerova LC, De GU, et al. Cerebrospinal fluid cytology in patients with ependymoma: a bi-institutional retrospective study. Cancer. 2008;114:307-314.
18. Paulino AC, Wen BC, Buatti JM, et al. Intracranial ependy-momas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol. 2002;25:117-122.
19. Miralbell R, Bieri S, Huguenin P, et al. Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma. Swiss Pediatric Oncology Group. Ann Oncol. 1999;10:239-241.
20. Pang J, Banerjee A, Tihan T. The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms. J Neurooncol. 2008;87: 97-102.